APAME 2026 Examines AI, Research Integrity, and the Future of Peer Review

Top medical editors and researchers gathered in Manila to discuss how scholarly publishing can preserve trust in an increasingly AI-enabled research environment.

The Asia Pacific Association of Medical Editors (APAME) 2026 Conference and the 7th Philippine Association of Medical Journal Editors (PAMJE) Conference brought together medical editors, researchers, reviewers, publishers, librarians, and health professionals at the Henry Sy Sr. Building of the University of the Philippines Manila on August 20–21, 2026.

The well-attended conference featured prominent leaders in medicine, health research, medical publishing, and public policy from the Philippines and the Asia-Pacific region. Distinguished speakers included Dr. Saia Ma’u Piukala, Regional Director for the Western Pacific of the World Health Organization; Usec. Leah Buendia of the Department of Science and Technology; Prof. Michael Tee, Chancellor of the University of the Philippines Manila; PAMJE president Prof. Cecilia Maramba-Lazarte; UP Medicine Dean Prof. Charlotte Chiong; and Prof. Nicholas Talley of the Medical Journal of Australia.

The program also brought together experts from the World Association of Medical Editors, APAME, PAMJE, universities, medical journals, research institutions, libraries, and government agencies.

The conference marked the presentation of the first-ever APAME Presidential Awards, recognizing Dr. Jose Florencio Lapeña Jr., concurrently President of WAME, and Dr. Wilfred C. G. Peh for their contributions to editorial excellence, publication ethics, peer-review education, and the advancement of medical publishing in the Asia-Pacific region and beyond.

Discussions focused on research integrity, responsible artificial intelligence use, the declining pool of peer reviewers, and concerns about citation quality in published research.

AI brings promise and new risks

Artificial intelligence can support literature searching, language editing, translation, data analysis, coding, knowledge synthesis, and dissemination.

However, it may also amplify plagiarism, fabricated references, undisclosed generated content, inappropriate authorship, manipulated data or images, paper-mill activity, and other forms of misconduct.

The key issue is not simply whether AI should be used, but whether its use is appropriate, transparent, verifiable, and accompanied by clear human accountability.

AI tools cannot be authors because they cannot take responsibility for the accuracy, originality, confidentiality, or integrity of a publication. Human authors remain responsible for all content, including AI-assisted text, references, analyses, tables, code, images, and interpretations.

The future of peer review

Participants also discussed the declining and uneven availability of qualified peer reviewers worldwide.

Peer review provides independent scrutiny of a manuscript’s research question, methods, analysis, interpretation, originality, relevance, and ethical conduct. However, journals increasingly struggle to find reviewers with the appropriate expertise, no conflicts of interest, and sufficient time to complete careful assessments.

The growing complexity of manuscripts, and the need to evaluate AI-assisted content, data, images, and references, has added to this pressure.

The conference also raised concerns about citation quality. References may be incomplete, irrelevant, inaccurately described, or difficult to verify. AI tools have introduced an additional risk by generating citations that appear plausible but do not exist or do not support the claims for which they are cited.

101 Health Research facilitates two workshops

As part of the program, 101 Health Research contributed two workshops facilitated by its Founder and Managing Director, Dr. Venus Oliva Cloma-Rosales:

• Publication Quality and Ethics in the AI Age: How to Comply with the Latest Publication Guidelines

• Medical Statistics for Non-Statisticians

The first workshop presented publication compliance as a continuous process beginning with study planning and extending through data management, analysis, reporting, peer review, publication, and post-publication correction.

It examined the traditional dimensions of publication quality of substance, form, and style, and the growing importance of a fourth dimension: integrity.

Integrity encompasses authorship, accountability, transparency, data governance, confidentiality, responsible AI use, conflict-of-interest disclosure, accurate citation, reproducibility, and correction of errors.

Participants reviewed guidance from ICMJE, WAME, COPE, the EQUATOR Network, professional organizations, institutions, funders, and target journals. The session emphasized that responsible AI use requires human verification, protection of confidential information, careful checking of references, and documentation of significant decisions.

The second workshop focused on the SAMPL Guidelines, or the Statistical Analyses and Methods in the Published Literature guidelines. These support clear reporting of statistical methods and results, including the software used, estimates, measures of uncertainty, p-values, and the relationship between statistical findings and the research question.

The workshop reinforced that statistical reporting is not merely a technical requirement. Clear reporting allows readers, reviewers, and editors to understand how conclusions were reached and assess whether they are supported by the data.

Preserving trust in medical publishing

The APAME 2026 discussions reinforced that research integrity is a shared responsibility. Authors must report their work transparently, reviewers must provide independent and fair assessments, and editors must apply consistent standards and respond appropriately to ethical concerns.

Artificial intelligence may make research and publishing more efficient, but efficiency cannot replace judgment. The future of medical publishing will depend on stronger human systems for verification, peer review, accountability, and learning.

For 101 Health Research, preserving trust begins with sound methods, responsible statistics, transparent reporting, and integrity at every stage of the research and publication process.

Learn more about 101 Health Research’s work in research methods, biostatistics, publication support, and research integrity at 101healthresearch.com.

  • Related Posts

    Carziqo Launches ER-BX Autonomous Ride-Hailing Operations in San Francisco

    The expansion brings the company’s ER-BX series to one of the United States’ most dynamic urban mobility markets, supported by continuous operations from Monday through Sunday. SAN FRANCISCO — Autonomous…

    Trans-Asiatic Trading Expands Distribution of Gerflor Streamo Marine Vinyl Flooring to Key Philippine Shipyards

    Trans-Asiatic Trading is extending the reach of its Wheelmark-approved Gerflor Streamo marine vinyl flooring range into the Philippine shipbuilding sector, strengthening its position as a trusted regional supplier of IMO-compliant…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    CAPTCHA


    You Missed

    Perkuat Keandalan Jalan Tol, PT Jasamarga Tollroad Maintenance Laksanakan Rekonstruksi Perkerasan di Ruas Tol Jagorawi

    Perkuat Keandalan Jalan Tol, PT Jasamarga Tollroad Maintenance Laksanakan Rekonstruksi Perkerasan di Ruas Tol Jagorawi

    Mengelola Uang Makan Harian agar Keuangan Tetap Teratur

    Mengelola Uang Makan Harian agar Keuangan Tetap Teratur

    Bitcoin Bangkit Lagi! BTC Tembus US$81.000, Level Ini Jadi Penentu Berikutnya

    Bitcoin Bangkit Lagi! BTC Tembus US.000, Level Ini Jadi Penentu Berikutnya

    Pembiayaan Dana Tunai BRI Finance Tumbuh 44,74% hingga Semester I-2026

    Pembiayaan Dana Tunai BRI Finance Tumbuh 44,74% hingga Semester I-2026

    Saat Kebutuhan Datang Tak Terduga, BRI Finance Hadirkan Solusi Dana yang Fleksibel

    Saat Kebutuhan Datang Tak Terduga, BRI Finance Hadirkan Solusi Dana yang Fleksibel

    Hadapi Tantangan Pasar Otomotif, BRI Finance Bukukan Pertumbuhan Laba 91,2%

    Hadapi Tantangan Pasar Otomotif, BRI Finance Bukukan Pertumbuhan Laba 91,2%